[
  {
    "displayName": "Gene",
    "description": "The goal of our drug perturbation pilot study is to identify signature profiles of cellular organization for a range of well-characterized agonists and antagonists commonly used to perturb specific cellular processes or pathways. ​The analysis not only shows the effects of these drugs on structures they are known to perturb but also on other structures providing a rich signature of pathway alterations.",
    "tooltip": "Gene expressed by hiPSCs",
    "unit": "gene",
    "key": "Gene",
    "discrete": true,
    "options": {
      "0": {
        "color": "#e9ebee",
        "name": "TUBA1B"
      },
      "1": {
        "color": "#c51b8a",
        "name": "SEC61B"
      },
      "2": {
        "color": "#fed98e",
        "name": "ACTB"
      },
      "3": {
        "color": "#fed98e",
        "name": "ST6GAL1"
      },
      "4": {
        "color": "#66c2a4",
        "name": "TJP1"
      },
      "5": {
        "color": "#7f48f3",
        "name": "MYH10"
      },
      "6": {
        "color": "#838383",
        "name": "LAMP1"
      }
    }
  },
  {
    "displayName": "Objective",
    "description": "The goal of our drug perturbation pilot study is to identify signature profiles of cellular organization for a range of well-characterized agonists and antagonists commonly used to perturb specific cellular processes or pathways. ​The analysis not only shows the effects of these drugs on structures they are known to perturb but also on other structures providing a rich signature of pathway alterations.",
    "tooltip": "Magnification of the Objective used to image cells",
    "unit": "magnification",
    "key": "Objective",
    "discrete": true,
    "options": {
      "0": {
        "color": "#fed98e",
        "name": "100"
      }
    }
  },
  {
    "displayName": "Structure",
    "description": "The goal of our drug perturbation pilot study is to identify signature profiles of cellular organization for a range of well-characterized agonists and antagonists commonly used to perturb specific cellular processes or pathways. ​The analysis not only shows the effects of these drugs on structures they are known to perturb but also on other structures providing a rich signature of pathway alterations.",
    "tooltip": "Cellular structure that was GFP tagged in imaged cells",
    "unit": "structure",
    "key": "Structure",
    "discrete": true,
    "options": {
      "0": {
        "color": "#e9ebee",
        "name": "Microtubules"
      },
      "1": {
        "color": "#c51b8a",
        "name": "Endoplasmic reticulum"
      },
      "2": {
        "color": "#838383",
        "name": "Actin filaments"
      },
      "3": {
        "color": "#fed98e",
        "name": "Golgi"
      },
      "4": {
        "color": "#66c2a4",
        "name": "Tight junctions"
      },
      "5": {
        "color": "#7f48f3",
        "name": "Actomyosin bundles"
      },
      "6": {
        "color": "#838383",
        "name": "Lysosome"
      }
    }
  },
  {
    "displayName": "Protein",
    "description": "The goal of our drug perturbation pilot study is to identify signature profiles of cellular organization for a range of well-characterized agonists and antagonists commonly used to perturb specific cellular processes or pathways. ​The analysis not only shows the effects of these drugs on structures they are known to perturb but also on other structures providing a rich signature of pathway alterations.",
    "tooltip": "Protein that is expressed with GFP tag in imaged cells",
    "unit": "protein",
    "key": "Protein_Name",
    "discrete": true,
    "options": {
      "0": {
        "color": "#e9ebee",
        "name": "Alpha-tubulin"
      },
      "1": {
        "color": "#c51b8a",
        "name": "Sec61 beta"
      },
      "2": {
        "color": "#838383",
        "name": "Beta-actin"
      },
      "3": {
        "color": "#fed98e",
        "name": "Sialyltransferase 1"
      },
      "4": {
        "color": "#66c2a4",
        "name": "Tight junction protein ZO-1"
      },
      "5": {
        "color": "#7f48f3",
        "name": "Non-muscle myosin heavy chain IIB"
      },
      "6": {
        "color": "#838383",
        "name": "LAMP-1"
      }
    }
  },
  {
    "displayName": "Drug Treatment Group",
    "description": "The goal of our drug perturbation pilot study is to identify signature profiles of cellular organization for a range of well-characterized agonists and antagonists commonly used to perturb specific cellular processes or pathways. ​The analysis not only shows the effects of these drugs on structures they are known to perturb but also on other structures providing a rich signature of pathway alterations.",
    "tooltip": "Are the imaged cells treated with drug or vehicle",
    "unit": "drug-or-vehicle",
    "key": "treatment_group",
    "discrete": true,
    "options": {
      "0": {
        "color": "#fed98e",
        "name": "Drug"
      },
      "1": {
        "color": "#7f48f3",
        "name": "Vehicle"
      }
    }
  },
  {
    "displayName": "Drug Time Point",
    "description": "The goal of our drug perturbation pilot study is to identify signature profiles of cellular organization for a range of well-characterized agonists and antagonists commonly used to perturb specific cellular processes or pathways. ​The analysis not only shows the effects of these drugs on structures they are known to perturb but also on other structures providing a rich signature of pathway alterations.",
    "tooltip": "How many hours after drug addition was imaging done",
    "unit": "hours",
    "key": "time_point",
    "discrete": true,
    "options": {
      "0": {
        "color": "#fed98e",
        "name": "0.5"
      },
      "1": {
        "color": "#7f48f3",
        "name": "1"
      },
      "2": {
        "color": "#e9ebee",
        "name": "2"
      },
      "3": {
        "color": "#838383",
        "name": "24"
      }
    }
  },
  {
    "displayName": "Drug Concentration",
    "description": "The goal of our drug perturbation pilot study is to identify signature profiles of cellular organization for a range of well-characterized agonists and antagonists commonly used to perturb specific cellular processes or pathways. ​The analysis not only shows the effects of these drugs on structures they are known to perturb but also on other structures providing a rich signature of pathway alterations.",
    "tooltip": "Concentration of Drug added to imaged cells, in units of \u00b5M",
    "unit": "\u00b5M",
    "key": "concentration",
    "discrete": false
  },
  {
    "displayName": "Drug Label",
    "description": "The goal of our drug perturbation pilot study is to identify signature profiles of cellular organization for a range of well-characterized agonists and antagonists commonly used to perturb specific cellular processes or pathways. ​The analysis not only shows the effects of these drugs on structures they are known to perturb but also on other structures providing a rich signature of pathway alterations.",
    "tooltip": "Name of drug added to cells",
    "unit": "",
    "key": "drug_label",
    "discrete": true,
    "options": {
      "0": {
        "color": "#e9ebee",
        "name": "Paclitaxel-Drug"
      },
      "1": {
        "color": "#e9ebee",
        "name": "Paclitaxel-Vehicle"
      },
      "2": {
        "color": "#c51b8a",
        "name": "Brefeldin-Drug"
      },
      "3": {
        "color": "#c51b8a",
        "name": "Brefeldin-Vehicle"
      },
      "4": {
        "color": "#fed98e",
        "name": "Staurosporine-Drug"
      },
      "5": {
        "color": "#fed98e",
        "name": "Staurosporine-Vehicle"
      },
      "6": {
        "color": "#66c2a4",
        "name": "s-Nitro-Blebbistatin-Drug"
      },
      "7": {
        "color": "#66c2a4",
        "name": "s-Nitro-Blebbistatin-Vehicle"
      },
      "8": {
        "color": "#7f48f3",
        "name": "Rapamycin-Drug"
      },
      "9": {
        "color": "#7f48f3",
        "name": "Rapamycin-Vehicle"
      }
    }
  },
  {
    "displayName": "FOV #",
    "description": "The goal of our drug perturbation pilot study is to identify signature profiles of cellular organization for a range of well-characterized agonists and antagonists commonly used to perturb specific cellular processes or pathways. ​The analysis not only shows the effects of these drugs on structures they are known to perturb but also on other structures providing a rich signature of pathway alterations.",
    "tooltip": "FOV #",
    "unit": "",
    "key": "fov_number",
    "discrete": false
  }
]